NDLI: Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care

Content Provider	PubMed Central
Author	Miller, Fiona A. Hayeems, Robin Z. Bytautas, Jessica P. Bedard, Philippe L. Ernst, Scott Hirte, Hal Hotte, Sebastien Oza, Amit Razak, Albiruni Welch, Stephen Winquist, Eric Dancey, Janet Siu, Lillian L.
Copyright Year	2014
Abstract	Developments in genomics, including next-generation sequencing technologies, are expected to enable a more personalized approach to clinical care, with improved risk stratification and treatment selection. In oncology, personalized medicine is particularly advanced and increasingly used to identify oncogenic variants in tumor tissue that predict responsiveness to specific drugs. Yet, the translational research needed to validate these technologies will be conducted in patients with late-stage cancer and is expected to produce results of variable clinical significance and incidentally identify genetic risks. To explore the experiential context in which much of personalized cancer care will be developed and evaluated, we conducted a qualitative interview study alongside a pilot feasibility study of targeted DNA sequencing of metastatic tumor biopsies in adult patients with advanced solid malignancies. We recruited 29/73 patients and 14/17 physicians; transcripts from semi-structured interviews were analyzed for thematic patterns using an interpretive descriptive approach. Patient hopes of benefit from research participation were enhanced by the promise of novel and targeted treatment but challenged by non-findings or by limited access to relevant trials. Family obligations informed a willingness to receive genetic information, which was perceived as burdensome given disease stage or as inconsequential given faced challenges. Physicians were optimistic about long-term potential but conservative about immediate benefits and mindful of elevated patient expectations; consent and counseling processes were expected to mitigate challenges from incidental findings. These findings suggest the need for information and decision tools to support physicians in communicating realistic prospects of benefit, and for cautious approaches to the generation of incidental genetic information.
Related Links	http://dx.doi.org/10.1038/ejhg.2013.158
Ending Page	395
Page Count	5
Starting Page	391
File Format	PDF
ISSN	14765438
e-ISSN	14765438
Journal	European Journal of Human Genetics
Issue Number	3
Volume Number	22
Language	English
Publisher	Nature Publishing Group
Publisher Date	2014-03-01
Access Restriction	Open
Rights Holder	Nature Publishing Group
Subject Keyword	Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Genetics Genetics (clinical)

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care

Application of Next Generation Sequencing for personalized medicine for sudden cardiac death

Next Generation DNA Sequencing and the Future of Genomic Medicine

Genetic-based biomarkers and next-generation sequencing: the future of personalized care in colorectal cancer

Application of Next Generation Sequencing for personalized medicine for sudden cardiac death

CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer

Pharmacogenomic Testing to Guide Personalized Cancer Medicine Decisions in Private Oncology Practice: A Case Study

Development and validation of next generation sequencing based 35-gene hereditary cancer panel

Next-generation sequencing for genetic testing of familial colorectal cancer syndromes

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care

Similar Documents

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care

Application of Next Generation Sequencing for personalized medicine for sudden cardiac death

Next Generation DNA Sequencing and the Future of Genomic Medicine

Genetic-based biomarkers and next-generation sequencing: the future of personalized care in colorectal cancer

Application of Next Generation Sequencing for personalized medicine for sudden cardiac death

CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer

Pharmacogenomic Testing to Guide Personalized Cancer Medicine Decisions in Private Oncology Practice: A Case Study

Development and validation of next generation sequencing based 35-gene hereditary cancer panel

Next-generation sequencing for genetic testing of familial colorectal cancer syndromes

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care